TITLE:
Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes

CONDITION:
Diabetes Mellitus, Type 2

INTERVENTION:
vildagliptin

SUMMARY:

      Many people with type 2 diabetes cannot maintain their target blood glucose levels on a
      single therapy. The purpose of this study is to assess the safety and effectiveness of
      vildagliptin, an unapproved drug, in lowering overall blood glucose levels when added to
      insulin in people with type 2 diabetes who are not at target blood glucose levels on insulin
      alone.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 80 Years
Criteria:

        Inclusion Criteria:

          -  Blood glucose criteria must be met

          -  On a stable dose of insulin as defined by the protocol

          -  Body mass inde (BMI) in the range 22-45

        Exclusion Criteria:

          -  Type 1 diabetes

          -  Pregnancy or lactation

          -  Evidence of serious diabetic complications

          -  Evidence of serious cardiovascular complications

          -  Laboratory value abnormalities as defined by the protocol

          -  Other protocol defined exclusion criteria may apply
      
